leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 20:32:12 - browse：897

IQVIA signage. -- health tech coverage from STAT — Adobe

The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Biogen nominates mother of director’s child to replace him on board

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

Apple Vision Pro: A first look at health apps on the new VR headset

Covid misinformation case heads to Supreme Court

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Even great ERs can’t make up for American health disparities

hotspot

leisure time

entertainment

Drug repurposing or repositioning? The language matters

The thinking behind the controversial eating disorder chatbot Tessa

Moonlake's readout produced a cash windfall. Risks remain

Bispecific antibodies are next new thing in cancer immunotherapy

The cancer drug shortage isn’t new — and neither are the solutions

Woodcock on FDA’s accelerated approval and her next chapter

Virginia high school admissions case could be legal follow

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Inside the rise of 'mukbang' eating videos

Wikipedia

Apple Vision Pro: A first look at health apps on the new VR headset

Biogen nominates mother of director’s child to replace him on board

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

The thinking behind the controversial eating disorder chatbot Tessa

Woodcock on FDA’s accelerated approval and her next chapter

explore

knowledge

focus

knowledge